400 related articles for article (PubMed ID: 32522960)
1. The Inhibitory Effect of Gut Microbiota and Its Metabolites on Colorectal Cancer.
Chen C; Li H
J Microbiol Biotechnol; 2020 Nov; 30(11):1607-1613. PubMed ID: 32522960
[TBL] [Abstract][Full Text] [Related]
2. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
3. Dietary probiotic and metabolites improve intestinal homeostasis and prevent colorectal cancer.
Peng M; Lee SH; Rahaman SO; Biswas D
Food Funct; 2020 Dec; 11(12):10724-10735. PubMed ID: 33231228
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota imbalance and colorectal cancer.
Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
[TBL] [Abstract][Full Text] [Related]
5. A Holistic View of Berberine Inhibiting Intestinal Carcinogenesis in Conventional Mice Based on Microbiome-Metabolomics Analysis.
Chen H; Zhang F; Zhang J; Zhang X; Guo Y; Yao Q
Front Immunol; 2020; 11():588079. PubMed ID: 33072135
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-derived metabolites in CRC progression and causation.
Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
[TBL] [Abstract][Full Text] [Related]
7. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
[TBL] [Abstract][Full Text] [Related]
8. Microbial Metabolites as Molecular Mediators of Host-Microbe Symbiosis in Colorectal Cancer.
Keane JM; Joyce SA; Gahan CGM; Hyland NP; Houston A
Results Probl Cell Differ; 2020; 69():581-603. PubMed ID: 33263888
[TBL] [Abstract][Full Text] [Related]
9. Can we change our microbiome to prevent colorectal cancer development?
Manzat-Saplacan RM; Mircea PA; Balacescu L; Chira RI; Berindan-Neagoe I; Balacescu O
Acta Oncol; 2015; 54(8):1085-95. PubMed ID: 26073561
[TBL] [Abstract][Full Text] [Related]
10. Intestinal Microbiota in Inflammatory Bowel Disease and Carcinogenesis: Implication for Therapeutics.
Bruner SD; Jobin C
Clin Pharmacol Ther; 2016 Jun; 99(6):585-7. PubMed ID: 26850686
[TBL] [Abstract][Full Text] [Related]
11. Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis.
Lu Y; Cui A; Zhang X
Gut Microbes; 2024; 16(1):2348441. PubMed ID: 38706224
[TBL] [Abstract][Full Text] [Related]
12. The role of microbiota in the development of colorectal cancer.
Dai Z; Zhang J; Wu Q; Chen J; Liu J; Wang L; Chen C; Xu J; Zhang H; Shi C; Li Z; Fang H; Lin C; Tang D; Wang D
Int J Cancer; 2019 Oct; 145(8):2032-2041. PubMed ID: 30474116
[TBL] [Abstract][Full Text] [Related]
13. Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy.
Zheng DW; Dong X; Pan P; Chen KW; Fan JX; Cheng SX; Zhang XZ
Nat Biomed Eng; 2019 Sep; 3(9):717-728. PubMed ID: 31332342
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression.
Wu H; Ma W; Wang Y; Wang Y; Sun X; Zheng Q
Biomed Pharmacother; 2024 Apr; 173():116410. PubMed ID: 38460373
[TBL] [Abstract][Full Text] [Related]
15. The roles of microbial products in the development of colorectal cancer: a review.
Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer.
Fan X; Jin Y; Chen G; Ma X; Zhang L
Digestion; 2021; 102(4):508-515. PubMed ID: 32932258
[TBL] [Abstract][Full Text] [Related]
17. Microbial metabolites in colorectal tumorigenesis and cancer therapy.
Liu Y; Lau HC; Yu J
Gut Microbes; 2023; 15(1):2203968. PubMed ID: 37095682
[TBL] [Abstract][Full Text] [Related]
18. Exploring the Role of Gut Microbiome in Colon Cancer.
Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
[TBL] [Abstract][Full Text] [Related]
19. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
20. Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer.
Gu M; Yin W; Zhang J; Yin J; Tang X; Ling J; Tang Z; Yin W; Wang X; Ni Q; Zhu Y; Chen T
Front Cell Infect Microbiol; 2023; 13():1119992. PubMed ID: 37265504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
